跳至主要内容
临床试验/CTRI/2019/05/018997
CTRI/2019/05/018997进行中(未招募)3 期

A randomized double blind controlled trial of Topiramate versus Propranolol in the prevention of chronic migraine: TOP-PRO STUDY - TOP-PRO STUDY

I0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients aged 18-65 years, either male or female who fulfills the diagnostic criteria laid down by ICHD 3 for Chronic migraine and not on any prophylactic treatment.

排除标准

  • All patients with a clinical phenotype of CM but on further investigation, found to have a
  • secondary cause for their headaches will be excluded. Pregnant women, patient with known
  • allergies against propranolol and/or topiramate, patients with history of bronchial asthma,
  • Chronic obstructive pulmonary disease (COPD), diabetes, bradycardia or heart blocks,
  • congestive heart failure (CHF), glaucoma, renal stones, dementia, psychosis and severe
  • depression shall be excluded from the study.

研究者

发起方
I

相似试验